<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR30">
 <label>30.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lee</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Bang</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Chang</surname>
    <given-names>YW</given-names>
   </name>
   <name>
    <surname>Choi</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Park</surname>
    <given-names>KY</given-names>
   </name>
   <name>
    <surname>Oh</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Han</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>SH</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Suh</surname>
    <given-names>JS</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Cancer theranosis using mono-disperse, mesoporous gold nanoparticles obtained via a robust, high-yield synthetic methodology</article-title>
  <source>RSC Adv</source>
  <year>2016</year>
  <volume>6</volume>
  <fpage>13554</fpage>
  <lpage>13561</lpage>
  <pub-id pub-id-type="doi">10.1039/C5RA24772A</pub-id>
 </element-citation>
</ref>
